Edition:
United Kingdom

CASI Pharmaceuticals Inc (CASI.OQ)

CASI.OQ on NASDAQ Stock Exchange Capital Market

4.10USD
16 Nov 2018
Change (% chg)

$0.58 (+16.48%)
Prev Close
$3.52
Open
$3.50
Day's High
$4.27
Day's Low
$3.48
Volume
202,267
Avg. Vol
97,269
52-wk High
$8.88
52-wk Low
$2.47

Latest Key Developments (Source: Significant Developments)

CASI Pharmaceuticals Acquires HBV ANDA From Laurus Labs Ltd
Tuesday, 23 Oct 2018 

Oct 23 (Reuters) - Laurus Labs Ltd ::CASI PHARMACEUTICALS ACQUIRES HBV ANDA FROM LAURUS LABS LIMITED.CASI PHARMACEUTICALS INC - CASI WILL MAKE CERTAIN UPFRONT AND MILESTONE PAYMENTS IN DIFFERENT PHASES.  Full Article

CASI Pharmaceuticals Announces $48.5 Mln Private Placement
Friday, 14 Sep 2018 

Sept 14 (Reuters) - CASI Pharmaceuticals Inc ::CASI PHARMACEUTICALS ANNOUNCES $48.5 MILLION PRIVATE PLACEMENT.CASI PHARMACEUTICALS ANNOUNCES $48.5 MILLION PRIVATE PLACEMENT.CASI PHARMACEUTICALS INC - PURCHASE PRICE FOR EACH SHARE OF COMMON STOCK AND WARRANT IS $5.36.CASI PHARMACEUTICALS - ENTERED DEFINITIVE SECURITIES PURCHASE AGREEMENTS UNDER WHICH CO TO ISSUE 9 MILLION SHARES OF COMMON STOCK.CASI PHARMACEUTICALS - UNDER AGREEMENT CO TO ALSO ISSUE ACCOMPANYING WARRANTS TO PURCHASE 2.7 MILLION SHARES.  Full Article

CASI Pharmaceuticals Q2 Loss Per Share $0.07
Tuesday, 14 Aug 2018 

Aug 14 (Reuters) - CASI Pharmaceuticals Inc ::CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER AND FIRST HALF 2018 FINANCIAL AND BUSINESS RESULTS.CASI PHARMACEUTICALS INC - CFDA REVIEW IN PROGRESS FOR MARQIBO AND ZEVALIN.CASI PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.07.  Full Article

Casi Pharmaceuticals Files For Offering Of Up To 17.3 Million Shares Of Co's Common Stock By Selling Stockholders
Tuesday, 17 Jul 2018 

July 17 (Reuters) - CASI Pharmaceuticals Inc ::CASI PHARMACEUTICALS FILES FOR OFFERING OF UP TO 17.3 MILLION SHARES OF CO'S COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING .  Full Article

Casi Pharmaceuticals Files Prospectus Relates To Up To 17.3 Mln Shares Of Co's Common Stock
Tuesday, 17 Jul 2018 

July 17 (Reuters) - CASI Pharmaceuticals Inc ::CASI PHARMACEUTICALS INC FILES PROSPECTUS RELATES TO UP TO 17.3 MILLION SHARES OF CO'S COMMON STOCK THAT MAY BE OFFERED FOR SALE BY SELLING - SEC FILING.  Full Article

CASI Pharmaceuticals Reports Q1 Loss Per Share Of $0.05
Tuesday, 15 May 2018 

May 15 (Reuters) - CASI Pharmaceuticals Inc ::CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2018 FINANCIAL AND BUSINESS RESULTS.Q1 LOSS PER SHARE $0.05.  Full Article

CASI Pharmaceuticals Q4 Loss Per Share $0.08
Thursday, 29 Mar 2018 

March 29 (Reuters) - CASI Pharmaceuticals Inc ::CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.08.AS OF DECEMBER 31, 2017, CASI HAD CASH AND CASH EQUIVALENTS OF APPROXIMATELY $43.5 MILLION.  Full Article

Casi Pharmaceuticals Files For Stock Shelf Of Upto $100 Million
Wednesday, 13 Dec 2017 

Dec 13 (Reuters) - Casi Pharmaceuticals Inc ::CASI PHARMACEUTICALS INC FILES FOR STOCK SHELF OF UPTO $100 MILLION - SEC FILING.  Full Article

Casi pharmaceuticals Q3 loss per share $0.03
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Casi Pharmaceuticals Inc :Casi Pharmaceuticals reports third quarter 2017 financial results.Q3 loss per share $0.03.As of September 30, 2017, Casi had cash and cash equivalents of approximately $21.6 million​.  Full Article